Exemestane Tablet, Film Coated
Product Images NDC 72603-329

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 72603-329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Exemestane Fig1)

Figure-1 (Exemestane Fig1)
This text provides statistical information about a clinical trial, including data on HR (Hazard Ratio), b(log-rank), the number of events and patients in each treatment group, and the duration of disease-free survival in months. The HR value indicates the ratio of hazards or risks between groups, while the log-rank p-value helps determine statistical significance in survival analysis. The table shows data for two treatment arms, TeamentRandomized and Tamoxifen, in terms of events, patients, and disease-free survival over time.*
FDA Label Image

Figure-2 (Exemestane Fig2)

Figure-2 (Exemestane Fig2)
FDA Label Image

Package Label-principal Display Panel (25 mg (30 Tablets Bottle))

Package Label-principal Display Panel (25 mg (30 Tablets Bottle))
This text contains information about Exemestane tablets, with each film-coated tablet containing 25 mg of Exemestane USP. The storage instructions recommend storing the tablets at a temperature between 20°C to 25°C (68°F to 77°F). The usual dosage information is not provided, and it refers to accompanying prescribing information. The manufacturing details indicate that the tablets are manufactured for Northstar Rx LLC in Memphis, TN, with the tablets being manufactured by Eugia Pharma Specialities Limited in India. The product is labeled as a product of India. The issue date of the product is September 2024. The NDC code for the tablets is 72603-329-01, and the packaging contains 30 tablets.*
FDA Label Image

Str (Exemestane Str)

Str (Exemestane Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.